Search Results

There are 15201 results for: content related to: Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  5. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD000208

  6. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  7. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Version of Record online : 27 JUL 2006, DOI: 10.1002/mds.20936

  8. The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2398–2403, Christopher G. Goetz, John G. Nutt and Glenn T. Stebbins

    Version of Record online : 21 NOV 2008, DOI: 10.1002/mds.22341

  9. Cholinergic medication for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Irina Tammenmaa, John McGrath, Eila ES Sailas and Karla Soares-Weiser

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD000207

  10. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22022

  11. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  12. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Version of Record online : 12 NOV 2008, DOI: 10.1002/mds.22208

  13. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Version of Record online : 16 JUL 2001, DOI: 10.1002/mds.1148

  14. Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 1–9, John G. Nutt

    Version of Record online : 6 SEP 2006, DOI: 10.1002/mds.21060

  15. Benzodiazepines for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Paranthaman Sethupathi Bhoopathi and Karla Soares-Weiser

    Published Online : 19 JUL 2006, DOI: 10.1002/14651858.CD000205.pub2

  16. Treatment of levodopa-induced motor complications

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S599–S612, Fabrizio Stocchi, Michele Tagliati and C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22052

  17. The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2084–2093, Tom H. Johnston, Susan H. Fox, Matthew J. Piggott, Juha-Matti Savola and Jonathan M. Brotchie

    Version of Record online : 7 SEP 2010, DOI: 10.1002/mds.23172

  18. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Version of Record online : 27 JAN 2010, DOI: 10.1002/mds.22960

  19. Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials

    European Journal of Neurology

    Volume 21, Issue 3, March 2014, Pages: 433–440, M. Chondrogiorgi, A. Tatsioni, H. Reichmann and S. Konitsiotis

    Version of Record online : 7 DEC 2013, DOI: 10.1111/ene.12318

  20. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1064–1071, C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi and for the Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Version of Record online : 29 APR 2013, DOI: 10.1002/mds.25364